文献速递产科

肩难产预测机器学习模型的开发与验证

Development and validation of a machine-learning model for prediction of shoulder dystocia.
PubMed 文献 · Ultrasound Obstet Gynecol · 2020-01-01

利用以色列 Sheba 医疗中心电子健康记录开发机器学习模型预测肩难产,并在美国加州大学旧金山医疗中心外部队列验证。建模队列 686 例单胎阴道分娩(131 例肩难产),验证队列 2584 例(31 例肩难产)。模型预测优于估测胎儿体重联合母亲糖尿病,并可对疑似巨大儿情境下的肩难产及新生儿损伤进行风险分层。

要点

  • 建模队列中模型 AUC 0.793±0.041,优于调整估测胎儿体重联合糖尿病的 0.745±0.044(P=1e-16)。
  • 验证队列中模型 AUC 0.866 vs 调整估测胎儿体重联合糖尿病 0.784(P=0.00007)。
  • 验证队列 aEFW≥4000 g 亚组 273 例中,aEFW 无预测力(AUC=0.548),模型 AUC 0.775(P=0.0002)。

核心结论

  • 开发了肩难产预测机器学习模型并在不同队列外部验证其性能。
  • 模型预测肩难产优于单用估测胎儿体重或估测胎儿体重联合母亲糖尿病。
  • 模型可在疑似巨大儿情境下对肩难产及新生儿损伤进行风险分层。

研究设计与样本

  • 使用以色列 Sheba 医疗中心电子健康记录开发模型(建模队列),使用美国加州大学旧金山医疗中心电子健康记录验证模型准确性与临床效能(验证队列)。
  • 应用纳入与排除标准后,建模队列纳入 686 例单胎阴道分娩,其中 131 例并发肩难产。
  • 验证队列纳入 2584 例分娩,其中 31 例并发肩难产。
  • 收集母亲与新生儿分娩结局、母亲人口学资料、产科临床数据及超声胎儿生物测量,生物测量及其衍生估测胎儿体重按分娩时孕周调整(aEFW)。
  • 采用机器学习流程开发模型。

主要发现

  • 建模队列中,模型 AUC 为 0.793±0.041,优于 aEFW 联合糖尿病的 AUC 0.745±0.044(P=1e-16)。
  • 增加肩难产风险的风险修正因素(beta>0.02):aEFW(beta=0.164)、孕前糖尿病(beta=0.047)、既往肩难产(beta=0.04)、女性胎儿性别(beta=0.04)、调整腹围(beta=0.03)。
  • 降低肩难产风险的保护性因素(beta<-0.02):调整双顶径(beta=-0.08)、母亲身高(beta=-0.03)。
  • 验证队列中模型 AUC 0.866 vs aEFW 联合糖尿病 0.784(P=0.00007)。
  • 验证队列 aEFW≥4000 g 的 273 例孕妇亚组中,aEFW 无预测力(AUC=0.548),模型 AUC 0.775(P=0.0002)。

关键数值与推荐

  • 风险评分阈值 0.5 将 42.9% 的分娩划为高风险组,该组包含 90.9% 的肩难产病例及全部伴母亲或新生儿并发症的病例。
  • 更特异的阈值 0.7 仅将 27.5% 的分娩划为高风险组,该组包含 63.6% 的肩难产病例及全部伴新生儿并发症的病例。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To develop a machine-learning (ML) model for prediction of shoulder dystocia (ShD) and to externally validate the model's predictive accuracy and potential clinical efficacy in optimizing the use of Cesarean delivery in the context of suspected macrosomia. METHODS: We used electronic health records (EHR) from the Sheba Medical Center in Israel to develop the model (derivation cohort) and EHR from the University of California San Francisco Medical Center to validate the model's accuracy and clinical efficacy (validation cohort). Subsequent to application of inclusion and exclusion criteria, the derivation cohort included 686 singleton vaginal deliveries, of which 131 were complicated by ShD, and the validation cohort included 2584 deliveries, of which 31 were complicated by ShD. For each of these deliveries, we collected maternal and neonatal delivery outcomes coupled with maternal demographics, obstetric clinical data and sonographic fetal biometry. Biometric measurements and their derived estimated fetal weight were adjusted (aEFW) according to gestational age at delivery. A ML pipeline was utilized to develop the model. RESULTS: In the derivation cohort, the ML model provided significantly better prediction than did the current clinical paradigm based on fetal weight and maternal diabetes: using nested cross-validation, the area under the receiver-operating-characteristics curve (AUC) of the model was 0.793 ± 0.041, outperforming aEFW combined with diabetes (AUC = 0.745 ± 0.044, P = 1e-16 ). The following risk modifiers had a positive beta that was > 0.02, i.e. they increased the risk of ShD: aEFW (beta = 0.164), pregestational diabetes (beta = 0.047), prior ShD (beta = 0.04), female fetal sex (beta = 0.04) and adjusted abdominal circumference (beta = 0.03). The following risk modifiers had a negative beta that was < -0.02, i.e. they were protective of ShD: adjusted biparietal diameter (beta = -0.08) and maternal height (beta = -0.03). In the validation cohort, the model outperformed aEFW combined with diabetes (AUC = 0.866 vs 0.784, P = 0.00007). Additionally, in the validation cohort, among the subgroup of 273 women carrying a fetus with aEFW ≥ 4000 g, the aEFW had no predictive power (AUC = 0.548), and the model performed significantly better (0.775, P = 0.0002). A risk-score threshold of 0.5 stratified 42.9% of deliveries to the high-risk group, which included 90.9% of ShD cases and all cases accompanied by maternal or newborn complications. A more specific threshold of 0.7 stratified only 27.5% of the deliveries to the high-risk group, which included 63.6% of ShD cases and all those accompanied by newborn complications. CONCLUSION: We developed a ML model for prediction of ShD and, in a different cohort, externally validated its performance. The model predicted ShD better than did estimated fetal weight either alone or combined with maternal diabetes, and was able to stratify the risk of ShD and neonatal injury in the context of suspected macrosomia. Copyright © 2019 ISUOG. Published by John Wiley & Sons Ltd.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Tsur A, Batsry L, Toussia-Cohen S, et al. Development and validation of a machine-learning model for prediction of shoulder dystocia. Ultrasound Obstet Gynecol. 2020. PMID: 31587401. doi:10.1002/uog.21878

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。